rs1220134

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_001111067.4(ACVR1):​c.1265-8474A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.377 in 152,058 control chromosomes in the GnomAD database, including 13,643 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.38 ( 13643 hom., cov: 32)

Consequence

ACVR1
NM_001111067.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.90

Publications

6 publications found
Variant links:
Genes affected
ACVR1 (HGNC:171): (activin A receptor type 1) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
ACVR1 Gene-Disease associations (from GenCC):
  • fibrodysplasia ossificans progressiva
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen, Orphanet
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.678 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACVR1NM_001111067.4 linkc.1265-8474A>T intron_variant Intron 9 of 10 ENST00000434821.7 NP_001104537.1 Q04771D3DPA4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACVR1ENST00000434821.7 linkc.1265-8474A>T intron_variant Intron 9 of 10 1 NM_001111067.4 ENSP00000405004.1 Q04771

Frequencies

GnomAD3 genomes
AF:
0.377
AC:
57244
AN:
151940
Hom.:
13602
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.685
Gnomad AMI
AF:
0.277
Gnomad AMR
AF:
0.248
Gnomad ASJ
AF:
0.347
Gnomad EAS
AF:
0.293
Gnomad SAS
AF:
0.176
Gnomad FIN
AF:
0.226
Gnomad MID
AF:
0.263
Gnomad NFE
AF:
0.266
Gnomad OTH
AF:
0.360
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.377
AC:
57341
AN:
152058
Hom.:
13643
Cov.:
32
AF XY:
0.369
AC XY:
27436
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.685
AC:
28403
AN:
41472
American (AMR)
AF:
0.248
AC:
3786
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.347
AC:
1204
AN:
3468
East Asian (EAS)
AF:
0.293
AC:
1514
AN:
5170
South Asian (SAS)
AF:
0.177
AC:
854
AN:
4818
European-Finnish (FIN)
AF:
0.226
AC:
2389
AN:
10558
Middle Eastern (MID)
AF:
0.272
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
0.266
AC:
18094
AN:
67960
Other (OTH)
AF:
0.362
AC:
765
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1562
3124
4685
6247
7809
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
510
1020
1530
2040
2550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.330
Hom.:
1252
Bravo
AF:
0.397
Asia WGS
AF:
0.270
AC:
937
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
15
DANN
Benign
0.75
PhyloP100
1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1220134; hg19: chr2-158603556; API